Off-label antineoplastic drugs. An effectiveness and safety study

Arroyo Álvarez, Cristina; Rodríguez Pérez, Lourdes; Rodríguez Mateos, María Eugenia; Martínez Bautista, María José; Benítez Rodríguez, Encarnación; Baena Cañada, José Manuel.
Farm. hosp ; 41(3): 382-390, mayo-jun. 2017. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-162876

Documentos relacionados

  1. Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials.
  2. Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.
  3. Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments.
  4. Reporting of Randomized Trials in Common Cancers in the Lay Media.
  5. How well are Phase 2 cancer trial publications supported by preclinical efficacy evidence?
  6. What patents tell us about drug repurposing for cancer: A landscape analysis.
  7. The proportion of North American cancer trials that evaluate novel targets.
  8. A dose-finding approach for genomic patterns in phase I trials.
  9. Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.
  10. Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.